In May 2012, the U.S. Preventive Services Task Force recommended against routine PSA screening (Prostate-Specific Antigentest to screen Prostate cancer) before being diagnosed as it did not benefit patients.
But UC David professor Michael Wilkes investigated and learned that the seminar was primarily a sales pitch about the prostate specificantigen (PSA) test, and that its main message was that men should get tested regularly beginning at age 40.